Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Oct 2, 2023. (Total: 221654Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 6 (of 6 Records)

Query Trace: Trisomy and KRAS[original query]
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
Blood 2013 Jan 121 (1): 170-7.
Paschka Peter, Du Juan, Schlenk Richard F, Gaidzik Verena I, Bullinger Lars, Corbacioglu Andrea, Späth Daniela, Kayser Sabine, Schlegelberger Brigitte, Krauter Jürgen, Ganser Arnold, Köhne Claus-Henning, Held Gerhard, von Lilienfeld-Toal Marie, Kirchen Heinz, Rummel Mathias, Götze Katharina, Horst Heinz-August, Ringhoffer Mark, Lübbert Michael, Wattad Mohammed, Salih Helmut R, Kündgen Andrea, Döhner Hartmut, Döhner Konstan
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome.
Blood cancer journal 2014 4 e177.
Chen T-C, Hou H-A, Chou W-C, Tang J-L, Kuo Y-Y, Chen C-Y, Tseng M-H, Huang C-F, Lai Y-J, Chiang Y-C, Lee F-Y, Liu M-C, Liu C-W, Liu C-Y, Yao M, Huang S-Y, Ko B-S, Hsu S-C, Wu S-J, Tsay W, Chen Y-C, Tien H
KRAS and aneusomy of chromosomes 4, 10 and 12 in colorectal carcinomas.
Pathology, research and practice 2015 Sep 211 (9): 646-51.
Beyer Kristin, Altendorf-Hofmann Annelore, Chen Yuan, Bickel Klaus, Petersen Iv
Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
Pathology, research and practice 2017 Jan .
Kwon Mi Jung, Kim Jeong Won, Jeon Jang Yong, Nam Eun Sook, Cho Seong Jin, Park Hye-Rim, Min Soo Kee, Seo Jinwon, Min Kyueng-Whan, Choe Ji-Young, Lee Hye Kyu
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival.
Leukemia 2019 3 33 (8): 2111-2115.
Vendramini Elena, Bomben Riccardo, Pozzo Federico, Benedetti Dania, Bittolo Tamara, Rossi Francesca Maria, Dal Bo Michele, Rabe Kari G, Pozzato Gabriele, Zaja Francesco, Chiarenza Annalisa, Di Raimondo Francesco, Braggio Esteban, Parikh Sameer A, Kay Neil E, Shanafelt Tait D, Del Poeta Giovanni, Gattei Valter, Zucchetto Antonel
Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study.
American journal of hematology 2020 4 95 (7): 799-808.
Rogers Heesun J, Wang Xiaoqiong, Xie Yan, Davis Adam R, Thakral Beenu, Wang Sa A, Borthakur Gautam, Cantu Miguel D, Margolskee Elizabeth M, Philip John K S, Sukhanova Madina, Bagg Adam, Bueso-Ramos Carlos E, Orazi Attilio, Arber Daniel A, Hsi Eric D, Hasserjian Robert
TOP